Raily Aesthetic Medicine International Holdings Limited

HKEX:2135.HK

0.11 (HKD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017
Revenue 189.384164.522188.367164.545191.156158.935112.932
Cost of Revenue 117.89197.739118.67584.37490.11866.44238.39
Gross Profit 71.49366.78369.69280.171101.03892.49374.542
Gross Profit Ratio 0.3780.4060.370.4870.5290.5820.66
Reseach & Development Expenses 1.602200000
General & Administrative Expenses 40.135.88234.72436.97119.9026.2952.722
Selling & Marketing Expenses 52.28549.28754.53333.13350.17244.66737.02
SG&A 92.38585.16989.25770.10470.07450.96239.742
Other Expenses 0-2.345-2.327-0.859-0.287-0.22-0.446
Operating Expenses 104.5486.94888.97666.85983.57763.15649.412
Operating Income -22.494-19.439-20.77512.62717.99829.1524.693
Operating Income Ratio -0.119-0.118-0.110.0770.0940.1830.219
Total Other Income Expenses Net -12.516-2.662-2.173-1.06-1.61-2.767-1.361
Income Before Tax -35.01-22.101-22.94811.56716.38826.38323.332
Income Before Tax Ratio -0.185-0.134-0.1220.070.0860.1660.207
Income Tax Expense 2.769-1.854-4.6826.6566.1117.9655.927
Net Income -32.457-15.911-17.6914.2519.89717.85517.379
Net Income Ratio -0.171-0.097-0.0940.0260.0520.1120.154
EPS -0.078-0.008-0.0090.0030.0050.0090.009
EPS Diluted -0.078-0.008-0.0090.0030.0050.0090.009
EBITDA -6.9963.754-6.24725.95529.75137.69832.201
EBITDA Ratio -0.0370.023-0.0330.1580.1560.2370.285